Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer's Dementia Are Frequently Below the Recommended Levels

• Príomhchruthaitheoirí: Marion Ortner (Údar), Marion Stange (Údar), Heike Schneider (Údar), Charlotte Schroeder (Údar), Katharina Buerger (Údar), Claudia Müller (Údar), Bianca Dorn (Údar), Oliver Goldhardt (Údar), Janine Diehl-Schmid (Údar), Hans Förstl (Údar), Werner Steimer (Údar), Timo Grimmer (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Frontiers Media S.A., 2020-05-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

BackgroundAcetylcholinesterase inhibitors (AChE-I) are recommended for the treatment of cognitive symptoms but also of behavioral and psychological symptoms in dementia. They are widely used not only in Alzheimer's disease, but also in other forms of dementia. Efficacy of treatment might depend...